TrialBritish journal of cancer2024

Fluoropyrimidine type, patient age, tumour sidedness and mutation status as determinants of benefit in patients with metastatic colorectal cancer treated with EGFR monoclonal antibodies: individual patient data pooled analysis of randomised trials from the ARCAD database.

C S Karapetis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.